Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2018-04-19 Report Publication Anno…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Annual Report and AGM Notice
Report Publication Announcement Classification · 99% confidence The document is very short (2750 characters) and explicitly states that the company 'confirms that it has today published the following documents on its website': the Annual Report, the AGM Notice/circular, and a proxy form. This structure—announcing the publication of other documents rather than containing the full content of those reports—fits the definition of a Report Publication Announcement (RPA). Although it mentions the Annual Report (10-K) and AGM Notice (AGM-R), the document itself is the announcement of their release. Since RPA is defined as 'Announcement regarding the timing, release, or publication of company reports,' this is the most accurate classification based on the 'MENU VS MEAL' rule.
2018-04-19 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 5279L' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of a Major Shareholding Notification. The content details the date the threshold was crossed (18 April 2018) and the resulting percentage of voting rights (2.99%). This aligns perfectly with the 'Major Shareholding Notification' category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2018-04-19 English
Hardman & Co Research: Alliance Pharma (APH): Entering the US market
Report Publication Announcement Classification · 98% confidence The document is a short announcement (4059 characters) from 'Hardman & Co Research' regarding Alliance Pharma (APH). It summarizes key findings about the company's strategy and recent performance (mentioning EBITDA growth and the Vamousse acquisition) and explicitly directs the reader to a PDF link for the 'full report'. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement that points to a full report is classified as a Report Publication Announcement (RPA). It is not the full report itself (like 10-K or IR), nor is it a standard regulatory filing like an ER or MRQ, but rather an announcement about the publication of research.
2018-04-19 English
Disposal of Chinese rights to Forceval
Regulatory Filings Classification · 99% confidence The document is explicitly marked with an "RNS Number" and contains the header "RNS Number : 0880L" followed by the date and company announcement. The content details a specific corporate transaction: the disposal of Chinese rights to a product via a subsidiary's joint venture sale for a cash consideration. This type of immediate, material corporate news release, especially one originating from the London Stock Exchange's news service (as indicated by the footer "This information is provided by RNS"), is typically classified as a general regulatory announcement or filing that doesn't fit into the more specific categories like 10-K, ER, or DIV. Since it is a specific announcement of a transaction rather than a general update or a report publication announcement (RPA), and it is clearly an RNS release, the most appropriate classification is Regulatory Filings (RNS).
2018-04-17 English
Alliance to present at the UK Investor Show
Regulatory Filings Classification · 98% confidence The document is a short announcement (2862 characters) released via RNS (RNS Number : 7753K) on April 13, 2018. The content explicitly states that Alliance Pharma PLC "will be presenting at the UK Investor Show" and provides details about the presentation time and executive availability. This is an announcement about the company's participation in an investor event, which aligns best with the category for general investor communications or announcements that don't fit a specific financial report type. Since it is an announcement about an upcoming investor event/presentation, it is closely related to Investor Presentation (IP) materials, but the document itself is just the announcement of attendance. Given the options, and the fact that it is a general regulatory news service release (RNS) announcing participation in an investor event, it could be classified as RNS (general regulatory filing) or potentially IP if the presentation itself was attached. However, since it is purely an announcement of attendance and presentation schedule, and it is short, it fits the criteria for a general regulatory announcement. If we consider the context of investor engagement, it is an announcement about an investor event. Since there is no specific category for 'Investor Event Announcement', and it is clearly a regulatory news service release, RNS is a strong candidate. However, the content is about presenting information to investors, which is the purpose of an Investor Presentation (IP). Given the short length and the nature of the announcement (not the presentation itself), Report Publication Announcement (RPA) or Regulatory Filings (RNS) are the most likely candidates based on the 'MENU VS MEAL' rule. Since it is a formal RNS release announcing participation in an investor show where management will present, RNS is the most accurate classification for the announcement itself, as it is not the presentation (IP) or a financial report.
2018-04-13 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with an "RNS Number" and contains a notification regarding the "Total Voting Rights" of Alliance Pharma PLC, citing compliance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of mandatory, short-form regulatory update, often distributed via the London Stock Exchange's news service (RNS), fits the definition of a general regulatory announcement that doesn't align with specific financial reports (10-K, IR, ER) or corporate actions (DIV, SHA, POS). Since it is a standard regulatory disclosure, the most appropriate classification is Regulatory Filings (RNS). The document length is short (2796 chars), supporting the idea that it is an announcement rather than a comprehensive report.
2018-04-03 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.